The Natural Killer Cells CD3-CD16+CD56+ (ABS) test is an advanced diagnostic tool with significant implications in the fields of immunology, oncology, and reproductive medicine. Natural Killer (NK) cells, a critical component of the innate immune system, play a vital role in the body’s first line of defense against tumors and virally infected cells. This test quantifies the absolute number of NK cells in the blood, specifically identifying the subset characterized by the absence of CD3 and the presence of CD16 and CD56 markers. High or abnormal levels of these cells can be indicative of various health conditions. Elevated NK cell levels may be associated with autoimmune disorders, chronic inflammation, and certain types of cancers. In reproductive medicine, an increased NK cell count is often scrutinized for its potential role in recurrent miscarriages and infertility issues, as these cells can impact implantation and placental development. Conversely, low levels of NK cells can suggest a weakened immune system, leaving individuals more susceptible to infections and possibly affecting cancer surveillance. The CD3-CD16+CD56+ (ABS) NK cells test is instrumental in providing crucial insights into the patient's immune system status, aiding in the diagnosis and management of diverse medical conditions. This test reflects the evolving landscape of medical diagnostics, emphasizing the importance of precise immunological assessments in personalized medicine and patient care. Its utilization in clinical practice underscores the growing reliance on detailed cellular analysis for diagnosing and managing complex health issues.
related to hookworms
Necroinflammatory Activity Grade reflects the level of active inflammation and liver cell injury occurring at the time of testing. It complements the Fibrosis Stage by showing how active the disease process is, rather than how much scarring has already formed. This grade is based on blood markers (such as ALT, AST, GGT, bilirubin, and others) and corresponds to the METAVIR scale: A0 (no activity), A1 (mild), A2 (moderate), and A3 (severe). A low grade (A0–A1) indicates stable or inactive liver disease with little current inflammation, while higher grades (A2–A3) mean that the liver is actively inflamed and at risk of progressive fibrosis if not addressed. Elevated grades are commonly linked to conditions such as fatty liver disease (MASLD/NASH), hepatitis B or C, alcohol-related liver injury, or autoimmune hepatitis. Managing the underlying cause—through treatment, alcohol avoidance, weight control, and metabolic care—can reduce inflammation and help protect against long-term liver damage.
Necroinflammatory Activity Score measures the level of active inflammation and liver cell injury, helping assess how “active” liver disease is at the time of testing. Unlike the Fibrosis Score, which reflects long-term scarring, this score indicates current inflammatory activity caused by conditions such as fatty liver disease (MASLD/NASH), viral hepatitis (B or C), or alcohol-related liver injury. Results range from A0 (no inflammation) to A3 (severe activity), with higher scores suggesting more intense inflammation and greater risk for future fibrosis progression. A low score (A0–A1) is reassuring and indicates stable liver health, while moderate to high scores (A2–A3) mean active inflammation that requires medical attention and lifestyle or treatment changes. Managing underlying causes, limiting alcohol, maintaining a healthy weight, and controlling blood sugar and cholesterol can help reduce inflammation and improve liver function over time.
a sexually transmitted disease (STD)
A monounsaturated fatty acid.
A monounsaturated fatty acid.
Omega-9 Fatty Acids
A monounsaturated fatty acid.
an omega-9 MUFA with a 24-carbon backbone and one double bond
play a central role in neurodegenerative diseases
an enzyme that is found in the cytoplasm of neurons and neuroendocrine cells